January 2026 in “Cronfa (Swansea University)” Finasteride and dutasteride may increase the risk of depression and suicidality, so patients should be monitored closely.
April 2026 in “Brain Sciences” This pharmacovigilance study analyzed FAERS data and found that finasteride is more frequently associated with neuropsychiatric reactions like depression and suicide risk, especially in younger men using it for alopecia, compared to dutasteride.
September 2025 in “Therapies” This study found that finasteride is associated with significant depressive effects, including an increased risk of suicidality, which can persist beyond 20 months after stopping the medication, even without prior sexual dysfunction or psychiatric history.
January 2026 in “International journal of research and scientific innovation” This paper reviews studies on stress-related biomarkers such as ghrelin, cortisol, and interleukin-6, highlighting their potential roles in stress and psychiatric illnesses, without providing new experimental data.
17 citations
,
August 2018 in “Clinics in Dermatology” This article discusses body-focused repetitive behaviors like trichotillomania and excoriation disorder, noting their higher prevalence than previously thought and the importance of dermatologic and psychiatric assessment in treatment; it reports no new clinical results.